80_FR_57562 80 FR 57378 - Center for Scientific Review; Notice of Closed Meetings

80 FR 57378 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 184 (September 23, 2015)

Page Range57378-57379
FR Document2015-24202

Federal Register, Volume 80 Issue 184 (Wednesday, September 23, 2015) 
[Federal Register Volume 80, Number 184 (Wednesday, September 23, 2015)]
[Notices]
[Pages 57378-57379]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-24202]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Cardiovascular and Respiratory Sciences 
Integrated Review Group; Cardiovascular Differentiation and 
Development Study Section.
    Date: October 15, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Sara Ahlgren, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, RM 4136, Bethesda, MD 20817-7814, 301-435-0904, 
[email protected].

    Name of Committee: Biological Chemistry and Macromolecular 
Biophysics Integrated Review Group; Synthetic and Biological 
Chemistry A Study Section.
    Date: October 15-16, 2015.
    Time: 8:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia, 
MD 21044.
    Contact Person: Mike Radtke, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4176, MSC 7806, Bethesda, MD 20892, 301-435-
1728, [email protected].

    Name of Committee: Biological Chemistry and Macromolecular 
Biophysics Integrated

[[Page 57379]]

Review Group; Macromolecular Structure and Function D Study Section.
    Date: October 15-16, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: Kinzie Hotel, 20 West Kinzie Street, Chicago, IL 60654.
    Contact Person: James W Mack, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4154, MSC 7806, Bethesda, MD 20892, (301) 435-
2037, [email protected].

    Name of Committee: Genes, Genomes, and Genetics Integrated 
Review Group; Genetic Variation and Evolution Study Section.
    Date: October 23, 2015.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Ronald Adkins, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 2206, MSC 7890, Bethesda, MD 20892, 301-435-
4511, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA Panel: NIH-PEPFAR Collaboration on Implementation Science 
for HIV.
    Date: October 26-27, 2015.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Shalanda A. Bynum, Ph.D., MPH, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive Room 3206, Bethesda, MD 20892, 301-435-
1165, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Psychosocial and Developmental Risk and 
Disease Prevention.
    Date: October 27, 2015.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Weijia Ni, Ph.D., Chief/Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD 
20892, (301) 594-3292, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: September 18, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-24202 Filed 9-22-15; 8:45 am]
BILLING CODE 4140-01-P

57378 Federal Register / Vol. 80, No. 184 / Wednesday, September 23, 2015 / Notices DEPARTMENT OF HEALTH AND Extramural Affairs, National Institute on (Catalogue of Federal Domestic Assistance HUMAN SERVICES Drug Abuse, National Institutes of Health, Program Nos.: 93.279, Drug Abuse and DHHS, 6001 Executive Boulevard, Room Addiction Research Programs, National National Institutes of Health 4234, MSC 9550, Bethesda, MD 02892, 301– Institutes of Health, HHS) 443–9511, jrao@nida.nih.gov. Name of Committee: National Institute on Dated: September 17, 2015. National Institute on Drug Abuse; Notice of Closed Meetings Drug Abuse Special Emphasis Panel; Tools Michelle Trout, and Services for Designing Methodologically Program Analyst, Office of Federal Advisory Pursuant to section 10(d) of the Rigorous Animal Studies. Committee Policy. Federal Advisory Committee Act, as Date: October 29, 2015. [FR Doc. 2015–24045 Filed 9–22–15; 8:45 am] amended (5 U.S.C. App), notice is Time: 10:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant BILLING CODE 4140–01–P hereby given of the following meetings. applications. The meetings will be closed to the Place: National Institutes of Health, public in accordance with the Neuroscience Center, 6001 Executive DEPARTMENT OF HEALTH AND provisions set forth in sections Boulevard, Rockville, MD 20852, (Telephone HUMAN SERVICES 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Conference Call). as amended. The grant applications and Contact Person: Gerald L. McLaughlin, National Institutes of Health the discussions could disclose Ph.D., Scientific Review Officer, Office of confidential trade secrets or commercial Extramural Affairs, National Institute on Center for Scientific Review; Notice of property such as patentable materials, Drug Abuse, NIH, DHHS, 6001 Executive Closed Meetings and personal information concerning Blvd., Room 4238, MSC 9550, Bethesda, MD 20892–9550, 301–402–6626, Pursuant to section 10(d) of the individuals associated with the grant gm145a@nih.gov. Federal Advisory Committee Act, as applications, the disclosure of which Name of Committee: National Institute on amended (5 U.S.C. App.), notice is would constitute a clearly unwarranted Drug Abuse Special Emphasis Panel; hereby given of the following meetings. invasion of personal privacy. Strategic Alliances for Medications The meetings will be closed to the Name of Committee: National Institute on Development to Treat Substance Use public in accordance with the Drug Abuse Special Emphasis Panel; Disorders (R01). provisions set forth in sections Mechanism for Time-Sensitive Drug Abuse Date: October 30, 2015. Research (R21). Time: 8:30 a.m. to 11:00 a.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Date: October 7, 2015. Agenda: To review and evaluate grant as amended. The grant applications and Time: 1:30 p.m. to 2:10 p.m. applications. the discussions could disclose Agenda: To review and evaluate grant Place: Hilton Garden Inn Bethesda, 7301 confidential trade secrets or commercial applications. Waverly Street, Bethesda, MD 20814. property such as patentable material, Place: National Institutes of Health, Contact Person: Jose F. Ruiz, Ph.D., and personal information concerning Neuroscience Center, 6001 Executive Scientific Review Officer, Office of individuals associated with the grant Boulevard, Rockville, MD 20852 (Telephone Extramural Affairs, National Institute on applications, the disclosure of which Conference Call). Drug Abuse, NIH, Room 4228, MSC 9550, would constitute a clearly unwarranted Contact Person: Hiromi Ono, Ph.D., 6001 Executive Blvd., Bethesda, MD 20892– Scientific Review Officer, Office of 9550, (301) 451–3086, ruizjf@nida.nih.gov. invasion of personal privacy. Extramural Affairs, National Institute on Name of Committee: National Institute on Name of Committee: Cardiovascular and Drug Abuse, National Institutes of Health, Drug Abuse Special Emphasis Panel; Grand Respiratory Sciences Integrated Review DHHS, 6001 Executive Boulevard, Room Opportunity in Medications Development for Group; Cardiovascular Differentiation and 4238, MSC 9550, Bethesda, MD 20892, 301– Substance-Related Disorders (U01). Development Study Section. 402–6020, hiromi.ono@nih.gov. Date: October 30, 2015. Date: October 15, 2015. Name of Committee: National Institute on Time: 11:00 a.m. to 1:00 p.m. Time: 8:00 a.m. to 6:00 p.m. Drug Abuse Special Emphasis Panel; Agenda: To review and evaluate Agenda: To review and evaluate grant Medication Development. cooperative agreement applications. applications. Date: October 8, 2015. Place: Hilton Garden Inn Bethesda, 7301 Place: Courtyard by Marriott, 5520 Time: 1:00 p.m. to 2:00 p.m. Waverly Street, Bethesda, MD 20814. Wisconsin Avenue, Chevy Chase, MD 20815. Agenda: To review and evaluate Contact Person: Jose F. Ruiz, Ph.D., Contact Person: Sara Ahlgren, Ph.D., cooperative agreement applications. Scientific Review Officer, Office of Scientific Review Officer, Center for Place: National Institutes of Health, Extramural Affairs, National Institute on Scientific Review, National Institutes of Neuroscience Center, 6001 Executive Drug Abuse, NIH, Room 4228, MSC 9550, Health, 6701 Rockledge Drive, RM 4136, Boulevard, Rockville, MD 20852 (Telephone 6001 Executive Blvd., Bethesda, MD 20892– Bethesda, MD 20817–7814, 301–435–0904, Conference Call). 9550, (301) 451–3086, ruizjf@nida.nih.gov. sara.ahlgren@nih.gov. Contact Person: Jose F. Ruiz, Ph.D., Name of Committee: National Institute on Name of Committee: Biological Chemistry Scientific Review Officer, Office of Drug Abuse Special Emphasis Panel; Cutting- and Macromolecular Biophysics Integrated Extramural Affairs, National Institute on Edge Basic Research Awards (CEBRA) (R21). Review Group; Synthetic and Biological Drug Abuse, NIH, Room 4228, MSC 9550, Date: November 18, 2015. Chemistry A Study Section. 6001 Executive Blvd., Bethesda, MD 20892– Time: 11:00 a.m. to 4:00 p.m. Date: October 15–16, 2015. 9550, (301) 451–3086, ruizjf@nida.nih.gov. Agenda: To review and evaluate grant Time: 8:00 a.m. to 1:00 p.m. Name of Committee: National Institute on applications. Agenda: To review and evaluate grant Drug Abuse Special Emphasis Panel; Place: National Institutes of Health, applications. Advancing Exceptional Research on HIV/ Neuroscience Center, 6001 Executive Place: Sheraton Columbia Hotel, 10207 AIDS and Substance Abuse (R01). Boulevard, Rockville, MD 20852 (Virtual Wincopin Circle, Columbia, MD 21044. mstockstill on DSK4VPTVN1PROD with NOTICES Date: October 15, 2015. Meeting). Contact Person: Mike Radtke, Ph.D., Time: 8:00 a.m. to 5:00 p.m. Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review Officer, Center for Agenda: To review and evaluate grant Scientific Review Officer, Office of Scientific Review, National Institutes of applications. Extramural Affairs, National Institute on Health, 6701 Rockledge Drive, Room 4176, Place: Hilton Garden Inn Bethesda, 7301 Drug Abuse, National Institutes of Health, MSC 7806, Bethesda, MD 20892, 301–435– Waverly Street, Bethesda, MD 20814. DHHS, 6001 Executive Boulevard, Room 1728, radtkem@csr.nih.gov. Contact Person: Jagadeesh S. Rao, Ph.D., 4234, MSC 9550, Bethesda, MD 02892, 301– Name of Committee: Biological Chemistry Scientific Review Officer, Office of 443–9511, jrao@nida.nih.gov. and Macromolecular Biophysics Integrated VerDate Sep<11>2014 18:00 Sep 22, 2015 Jkt 235001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\23SEN1.SGM 23SEN1

Federal Register / Vol. 80, No. 184 / Wednesday, September 23, 2015 / Notices 57379 Review Group; Macromolecular Structure DEPARTMENT OF HEALTH AND other individuals with professional or and Function D Study Section. HUMAN SERVICES personal experience with muscular Date: October 15–16, 2015. dystrophy. In accordance with White Time: 8:00 a.m. to 5:00 p.m. National Institutes of Health House Office of Management and Agenda: To review and evaluate grant applications and/or proposals. Budget guidelines (FR Doc. 2014– National Institute of Neurological 19140), federally-registered lobbyists are Place: Kinzie Hotel, 20 West Kinzie Street, Chicago, IL 60654. Disorders and Stroke, Muscular not eligible. Contact Person: James W Mack, Ph.D., Dystrophy Coordinating Committee Committee Composition: The Scientific Review Officer, Center for Call for Committee Membership Department strives to ensure that the Scientific Review, National Institutes of Nominations membership of HHS Federal advisory Health, 6701 Rockledge Drive, Room 4154, committees is fairly balanced in terms of MSC 7806, Bethesda, MD 20892, (301) 435– SUMMARY: The Office of the Secretary of the Department of Health and Human points of view represented and the 2037, mackj2@csr.nih.gov. Services (HHS) is seeking nominations committee’s function. Every effort is Name of Committee: Genes, Genomes, and made to ensure that the views of all Genetics Integrated Review Group; Genetic for an individual to serve as a non- Variation and Evolution Study Section. federal public member on the Muscular genders, all ethnic and racial groups, Date: October 23, 2015. Dystrophy Coordinating Committee. and people with disabilities are Time: 8:00 a.m. to 7:00 p.m. DATES: Nominations are due by 5 p.m., represented on HHS Federal advisory Agenda: To review and evaluate grant October 26, 2015. committees and, therefore, the applications. Department encourages nominations of Place: Residence Inn Bethesda, 7335 ADDRESSES: Nominations must be sent qualified candidates from these groups. Wisconsin Avenue, Bethesda, MD 20814. to Glen Nuckolls, Ph.D., by email to The Department also encourages Contact Person: Ronald Adkins, Ph.D., nuckollg@ninds.nih.gov. geographic diversity in the composition Scientific Review Officer, Center for FOR FURTHER INFORMATION CONTACT: Glen Scientific Review, National Institutes of of the Committee. Appointment to this Nuckolls, Ph.D., by email to nuckollg@ Committee shall be made without Health, 6701 Rockledge Drive, Room 2206, ninds.nih.gov. discrimination on the basis of age, race, MSC 7890, Bethesda, MD 20892, 301–435– 4511, ronald.adkins@nih.gov. SUPPLEMENTARY INFORMATION: The ethnicity, gender, sexual orientation, Name of Committee: Center for Scientific Muscular Dystrophy Coordinating disability, and cultural, religious, or Review Special Emphasis Panel; RFA Panel: Committee (MDCC) is a federal advisory socioeconomic status. Requests for NIH–PEPFAR Collaboration on committee established in accordance reasonable accommodation to enable Implementation Science for HIV. with the Muscular Dystrophy participation on the Committee should Date: October 26–27, 2015. Community Assistance, Research, and be indicated in the nomination Time: 9:00 a.m. to 5:00 p.m. Education Amendments of 2001 (MD– submission. Agenda: To review and evaluate grant CARE Act; Pub. L. 107–84). The MD– applications. Member Terms: Non-Federal public Place: Hyatt Regency Bethesda, One CARE Act was reauthorized in 2008 by members of the Committee serve for a Bethesda Metro Center, 7400 Wisconsin Public Law 110–361, and again in 2014 term of 3 years, and may serve for an Avenue, Bethesda, MD 20814. by Public Law 113–166. The MD–CARE unlimited number of terms if Contact Person: Shalanda A. Bynum, Act specifies that the committee reappointed. Members may serve after Ph.D., MPH, Scientific Review Officer, Center membership be composed of 2⁄3 the expiration of their terms, until their for Scientific Review, National Institutes of governmental agency representatives successors have taken office. Health, 6701 Rockledge Drive Room 3206, and 1⁄3 public members. We are seeking Meetings and Travel: As specified by Bethesda, MD 20892, 301–435–1165, nominations for a non-federal, public Public Law 113–166, the MDCC ‘‘shall bynumsa@csr.nih.gov. member at this time, due to turnover of meet no fewer than two times per Name of Committee: Center for Scientific committee membership. Nominations Review Special Emphasis Panel; Member calendar year.’’ Travel expenses are Conflict: Psychosocial and Developmental will be accepted between September 25, provided for non-federal public Risk and Disease Prevention. 2015 and October 26, 2015. Committee members to facilitate Date: October 27, 2015. Who is Eligible: Nominations for a attendance at in-person meetings. Time: 1:00 p.m. to 4:00 p.m. new non-federal public member Members are expected to make every Agenda: To review and evaluate grant interested in providing the public and/ effort to attend all full committee applications. or patient perspective are encouraged. meetings, twice per year, either in Place: National Institutes of Health, 6701 Self-nominations and nominations of person or via remote access. Rockledge Drive, Bethesda, MD 20892, other individuals are both permitted. (Virtual Meeting). Participation in relevant subcommittee, Only one nomination per individual is working and planning group meetings, Contact Person: Weijia Ni, Ph.D., Chief/ Scientific Review Officer, Center for required. Multiple nominations for the and workshops, is also encouraged. Scientific Review, National Institutes of same individual will not increase Submission Instructions and Health, 6701 Rockledge Drive, Room 3100, likelihood of selection. Non-federal, Deadline: Nominations are due by 5 MSC 7808, Bethesda, MD 20892, (301) 594– public members may be selected from p.m. EST on October 26, 2015, and 3292, niw@csr.nih.gov. the pool of submitted nominations or should be sent to Glen Nuckolls, Ph.D., (Catalogue of Federal Domestic Assistance other sources as needed to meet by email to nuckollg@ninds.nih.gov. Program Nos. 93.306, Comparative Medicine; statutory requirements and to form a Nominations must include contact 93.333, Clinical Research, 93.306, 93.333, balanced committee that represents the information for the nominee, a current 93.337, 93.393–93.396, 93.837–93.844, diversity within the muscular dystrophy curriculum vitae or resume of the 93.846–93.878, 93.892, 93.893, National mstockstill on DSK4VPTVN1PROD with NOTICES Institutes of Health, HHS) communities. Those eligible for nominee and a paragraph describing the nomination include leaders or qualifications of the person to represent Dated: September 18, 2015. representatives of major muscular some portion(s) of the muscular David Clary, dystrophy research, advocacy, and dystrophy research, advocacy and/or Program Analyst, Office of Federal Advisory service organizations, parents or patient care communities. Committee Policy. guardians of individuals with muscular More information about the MDCC is [FR Doc. 2015–24202 Filed 9–22–15; 8:45 am] dystrophy, individuals with muscular available at http://www.ninds.nih.gov/ BILLING CODE 4140–01–P dystrophy, educators, researchers, and about_ninds/groups/mdcc/. VerDate Sep<11>2014 18:00 Sep 22, 2015 Jkt 235001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\23SEN1.SGM 23SEN1


Document Created: 2015-12-15 09:45:29
Document Modified: 2015-12-15 09:45:29
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesOctober 15, 2015.
FR Citation80 FR 57378 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR